Adults 18 to 55, any sex, with Emotions. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The Ability to Perceive Negative and Positive Emotional Expressions, as Measured by a Behavioral Computer-based AssessmentPrimary· During the laboratory experiment (week 1)
Emotion perception is measured by a computer-based behavioral assessment during the laboratory session. Scores for negative emotional expressions range from 0-100%, with higher scores indicating greater emotion perception accuracy.
Group
Value
95% CI
Mindful Breathing
77.31
± 14.36
Habituation
81.93
± 17.94
Control
84.85
± 16
Changes in Emotion Perception, as Measured by a Phone-based Behavioral AssessmentPrimary· After the one week of phone-based intervention
Perception of positive emotional expressions and negative emotional expressions are measured by a behavioral phone-based assessment, delivered multiple times over one week via mobile phones. Scores for ratings of emotional valence range from 0-9, with higher scores as more positive emotional valence and lower scores as more negative emotional valence.
Group
Value
95% CI
Mindful Breathing
5.19
± 2.57
Habituation
5.3
± 2.54
Control
5.23
± 2.59
Change in Emotional Distress, as Measured by Subjective Units of Distress (SUDS)Secondary· Beginning of Week one laboratory experiment, End of Week one laboratory experiment
SUDS are measured on a 10-point Likert self-report scale of Subjective Units of Distress, ranging from 0-9. Scores are changes in SUDS ratings from before hearing the tone to after the tone, with greater scores indicating greater reductions in distress (positive outcomes). SUDS score was evaluated at the beginning of the laboratory experiment, and then at the very end of the lab experiment. The change score was calculated by subtracting the beginning score from the end score.
Group
Value
95% CI
Mindful Breathing
1.14
± 1.21
Habituation
0.61
± 0.9
Control
0.56
± 0.95
Sponsor's own description
The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT05433389 — App Delivered Brief Mindfulness Intervention for Surgical Patients
· NA
· active not recruiting
NCT05349123 — A Home-based Intervention to Promote Mindful Breathing Awareness Through Pursed-lip Breathing Training for COPD Patients
· NA
· completed
NCT06656741 — Neurological Evidence of Diverse Self-Help Breathing Trainings with Virtual Reality and Bio-Feedback Assistance
· NA
· completed
NCT03897699 — Mindful Breathing and tDCS for Depression
· NA
· completed
Other recruiting trials for Emotions
Currently open trials in the same condition.
NCT06808776 — Stories to Prevent (StoP) HPV Cancers
· NA
· recruiting
NCT05991713 — Geolocation Positional System (GPS) Experience
· NA
· recruiting
NCT05645835 — Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults
· NA
· active not recruiting
NCT06056674 — Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)
· NA
· active not recruiting
NCT05949047 — Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
· NA
· recruiting
Other Duke University trials
Trials by the same sponsor.
NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation
· NA
· not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment
· NA
· not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
· Phase 1
· not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
· NA
· not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 24 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03790878.